{
    "meta": {
        "totalResults": 1,
        "from": 0
    },
    "results": [
        {
            "aliases": [
                {
                    "type": "USBrandName",
                    "name": "Mycobutin"
                },
                {
                    "type": "CASRegistryName",
                    "name": "72559-06-9"
                }
            ],
            "definition": {
                "html": "A semisynthetic ansamycin antibiotic with potent antimycobacterial properties.  Rifabutin inhibits bacterial DNA-dependent RNA polymerase, thereby suppressing the initiation of RNA formation and leading to inhibition of RNA synthesis and transcription. Check for <a ref=\"https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1408\">active clinical trials</a> using this agent. (<a ref=\"https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1408\">NCI Thesaurus</a>)",
                "text": "A semisynthetic ansamycin antibiotic with potent antimycobacterial properties.  Rifabutin inhibits bacterial DNA-dependent RNA polymerase, thereby suppressing the initiation of RNA formation and leading to inhibition of RNA synthesis and transcription. Check for active clinical trials using this agent. (NCI Thesaurus)"
            },
            "drugInfoSummaryLink": null,
            "nciConceptId": "C1408",
            "nciConceptName": "Rifabutin",
            "termId": 37812,
            "name": "rifabutin",
            "firstLetter": "r",
            "type": "DrugTerm",
            "termNameType": "PreferredName",
            "prettyUrlName": "rifabutin"
        }
    ],
    "links": null
}